Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03615781
Other study ID # no. 15-014
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2015
Est. completion date May 18, 2018

Study information

Verified date July 2018
Source University Hospital, Geneva
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allowing up to 3 surgical lavages and allocating patients into a two-week's and a four week's randomization arm


Description:

The optimal duration of systemic antibiotic administration for native joint septic arthritis is unknown. The investigators perform a randomized study allocating patients into a two-week's and a four week's randomization arm.

The adult patients are hospitalized for septic arthritis. A computer program randomizes 1:1 between a two week's and a four week's arm of targeted antibiotic treatment of which at least the first week is intravenously. The randomization may occur until Day 5 of admission. Up to three surgical interventions are allowed. The investigators allow the inclusion of all bacterial arthritis and all joints.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date May 18, 2018
Est. primary completion date April 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 120 Years
Eligibility Inclusion Criteria:

1. Age >17 years

2. Microbiologically-confirmed septic arthritis

3. At least one surgical drainage/lavage

Exclusion Criteria:

1. Presence of osteosynthesis material in the vicinity of the articulation

2. Presence of a concomitant infection needing more than 2 week's of antibiotic therapy

3. More than 3 surgical drainages

4. Life expectancy less than 6 months

5. Chronic osteomyelitis in vicinity of the arthritis

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Two week's arm - surgery
The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.
Four week's arm - surgery
The investigators perform a surgical drainage of the infection along with the complete removal of the infected orthopedic implant.
Drug:
Two week's arm - drugs
After the surgical implant removal, the investigators prescribe a total of 2 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.
Four week's arm - drugs
After the surgical implant removal, the investigators prescribe a total of 4 weeks of systemic targeted antibiotic therapy against the causative pathogen(s), of which one week is recommended to be intravenously.

Locations

Country Name City State
Switzerland Geneva University Hospitals Geneva

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland, 

References & Publications (1)

Uçkay I, Tovmirzaeva L, Garbino J, Rohner P, Tahintzi P, Suvà D, Assal M, Hoffmeyer P, Bernard L, Lew D. Short parenteral antibiotic treatment for adult septic arthritis after successful drainage. Int J Infect Dis. 2013 Mar;17(3):e199-205. doi: 10.1016/j.ijid.2011.12.019. Epub 2012 Nov 22. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical Remission of systemic infection Measurement of fever. 6 months
Primary Sequels Patient's remaining gait disorders.
range of movement in adjacent joints of former infection
questionnaire regarding persistant pain and handicaps (open wording)
6 months
Secondary Wound redness Visual examination of the presence of wound redness. 6 months
Secondary Wound discharge Visual examination of the presence of wound discharge 6 months
Secondary Presence of pus Visual examination of the presence of pus coming out the wound 6 months
See also
  Status Clinical Trial Phase
Completed NCT04460144 - Rapid Diagnostic Test for Septic Arthritis
Recruiting NCT05531227 - Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint